Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Spada

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 15, 2016
Screening of PRKAR1A and PDE4D in a Large Italian Series of Patients Clinically Diagnosed With Albright Hereditary Osteodystrophy and/or PseudohypoparathyroidismFrancesca Marta Elli, Paolo Bordogna, Luisa de Sanctis, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factorsCristina L Ronchi, Virginia Varca, Paolo Beck-Peccoz, et al.
Molecular and Cellular Endocrinology|January 11, 2021
Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cellsDonatella Treppiedi, Genesio Di Muro, Federica Mangili, et al.
Gene|July 10, 2012
A new structural rearrangement associated to Wolfram syndrome in a child with a partial phenotypeFrancesca M Elli, Stefano Ghirardello, Claudia Giavoli, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterationsFrancesca M Elli, Luisa de Sanctis, Valentina Bollati, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2015
Hypercalciuria May Persist After Successful Parathyroid Surgery and It Is Associated With Parathyroid HyperplasiaSerena Palmieri, Cristina Eller-Vainicher, Elisa Cairoli, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumorsGiovanna Mantovani, Sara Bondioni, Andrea G Lania, et al.
Neuroendocrinology|June 9, 2020
Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on AKT Phosphorylation and Cell Proliferation in Pituitary TumorsFederica Mangili, Elena Giardino, Donatella Treppiedi, et al.
European Journal of Endocrinology|February 9, 2011
Long-term effects of radiotherapy on cardiovascular risk factors in acromegalyCristina L Ronchi, Elisa Verrua, Emanuele Ferrante, et al.
Experimental Biology and Medicine (Maywood, N.J.)|March 28, 2008
Effect of 9-cis retinoic acid on dopamine D2 receptor expression in pituitary adenoma cellsSara Bondioni, Anita R Angioni, Sabrina Corbetta, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 15, 2016
Screening of PRKAR1A and PDE4D in a Large Italian Series of Patients Clinically Diagnosed With Albright Hereditary Osteodystrophy and/or PseudohypoparathyroidismFrancesca Marta Elli, Paolo Bordogna, Luisa de Sanctis, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factorsCristina L Ronchi, Virginia Varca, Paolo Beck-Peccoz, et al.
Molecular and Cellular Endocrinology|January 11, 2021
Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cellsDonatella Treppiedi, Genesio Di Muro, Federica Mangili, et al.
Gene|July 10, 2012
A new structural rearrangement associated to Wolfram syndrome in a child with a partial phenotypeFrancesca M Elli, Stefano Ghirardello, Claudia Giavoli, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterationsFrancesca M Elli, Luisa de Sanctis, Valentina Bollati, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2015
Hypercalciuria May Persist After Successful Parathyroid Surgery and It Is Associated With Parathyroid HyperplasiaSerena Palmieri, Cristina Eller-Vainicher, Elisa Cairoli, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumorsGiovanna Mantovani, Sara Bondioni, Andrea G Lania, et al.
Neuroendocrinology|June 9, 2020
Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on AKT Phosphorylation and Cell Proliferation in Pituitary TumorsFederica Mangili, Elena Giardino, Donatella Treppiedi, et al.
European Journal of Endocrinology|February 9, 2011
Long-term effects of radiotherapy on cardiovascular risk factors in acromegalyCristina L Ronchi, Elisa Verrua, Emanuele Ferrante, et al.
Experimental Biology and Medicine (Maywood, N.J.)|March 28, 2008
Effect of 9-cis retinoic acid on dopamine D2 receptor expression in pituitary adenoma cellsSara Bondioni, Anita R Angioni, Sabrina Corbetta, et al.
Pageof 13